Cobicistat and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Cobicistat (cobicistat), especially for people who are male, 60+ old, also take Emtricitabine, and have Sedation.

The study is created by eHealthMe based on reports of 471 people who have side effects when taking Cobicistat from the FDA, and is updated regularly.

What is Cobicistat?

Cobicistat has active ingredients of cobicistat. eHealthMe is studying from 471 Cobicistat users. Check the latest studies of Cobicistat.

On Jul, 14, 2026

471 people reported to have side effects when taking Cobicistat.
Among them, 12 people (2.55%) died.

Among these 12 people:

What is the gender of people who died when taking Cobicistat? *

female: 20 %
male: 80 %

What is the age of people who died when taking Cobicistat? *

What are other drugs people take besides Cobicistat? *

What are other side effects people have before they died? *

Speech Impairment (Adult) (inability to speak (adult)): 3 people, 25.00%
Disability: 3 people, 25.00%
Acidosis (build-up of carbon dioxide in the blood): 2 people, 16.67%
Wernicke's Encephalopathy (ocular disturbances, changes in mental state, unsteady stance and gait due to deficiency of vit.b1): 1 person, 8.33%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 1 person, 8.33%
Rectal Cancer Metastatic (cancer of rectum spreads to other): 1 person, 8.33%
Procedural Haemorrhage (procedural bleeding): 1 person, 8.33%
Hyperkalemia (damage to or disease of the kidney): 1 person, 8.33%
Haematoma (collection of blood outside the blood vessels): 1 person, 8.33%
Fluid Overload (too much fluid in the blood): 1 person, 8.33%

What are the existing conditions these people have? *

Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 16.67%
Sedation: 2 people, 16.67%
Nausea And Vomiting: 1 person, 8.33%
Nausea (feeling of having an urge to vomit): 1 person, 8.33%
Hiv Infection: 1 person, 8.33%
Dry Eyes (lack of adequate tears): 1 person, 8.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cobicistat:

Cobicistat (471 reports)

Expand to all the drugs that have ingredients of cobicistat:

Death and drugs with ingredients of cobicistat

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cobicistat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,125 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cobicistat (the active ingredients of Cobicistat) and Cobicistat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.